Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07491926

MASKd: a Study on Kawasaki Disease (KD) Complicated by Macrophage Activation Syndrome (MAS)

Sponsor: Meyer Children's Hospital IRCCS

View on ClinicalTrials.gov

Summary

Kawasaki Disease (KD) is one of the most common vasculitides in childhood and represents a leading cause of acquired heart disease in developed countries. Macrophage Activation Syndrome (MAS) is a potentially life threatening hyperinflammatory condition belonging to the spectrum of hemophagocytic lymphohistiocytosis (HLH), and it can complicate various rheumatologic diseases. Awareness of MAS in the context of KD has recently increased, supporting the hypothesis that it is an underdiagnosed complication. The study aims to define the epidemiology, clinical characteristics, management, and therapeutic strategies of MAS in patients with KD, through a multicenter data collection in Europe.

Official title: MACROPHAGE ACTIVATION SYNDROME IN KAWASAKI DISEASE: Features, Treatment, Outcome, Predictive and Diagnostic Factors (The MASKd Study)

Key Details

Gender

All

Age Range

4 Weeks - 17 Years

Study Type

OBSERVATIONAL

Enrollment

150

Start Date

2026-02

Completion Date

2029-02

Last Updated

2026-03-25

Healthy Volunteers

No

Locations (1)

Azienda Ospedaliero-Universitaria IRCCS Meyer

Florence, Italy, Italy